YTD the account is up almost 16%…..which is in line with the goal of 1-2% growth per month. The returns were much higher in 2020 but it was much easier to generate returns last year. We are more conservative this year with almost a third of the account in cash. Last week the account hit a new high for the first time since late April.
Table below is the current portfolio. All positions have/had call options written against the stock. ABT also has a short put option written as I would be okay with getting assigned and increasing the position. The put was written when the stock recently dipped (after reducing revenue and earnings guidance) and I was looking for a bounce back.
CFLT is a new position opened following their recent IPO. It should be an interesting stock to follow.
10 of the 12 positions are net profitable. Overall the options are generating negative returns in 6 of the 12 positions. I have been writing further “out of the money” strike prices to try and improve this.
Dexcom (DXCM) has been on a roll lately resulting in higher profits on the stock but forcing us to “roll up” at losses.
NIO remains a challenge as my timing never seems to match up. When the stock drops I say “why am I playing with such a volatile Chinese based stock and I sell….only to get pulled back in with all the hype and high premiums.
BCRX has been a great performer generating $86,137 in net profit so far. Option premiums are great and stock has performed well over the past year. PODD (Insulet) was also a new addition to the portfolio. Premiums are surprisingly high.